Navigation Links
NIH grant to strengthen IU and Purdue program to educate physician-scientists
Date:7/10/2008

INDIANAPOLIS An Indiana University School of Medicine program that partners with Purdue University to train the next generation of physician-scientists has been given national recognition with a prestigious grant from the National Institutes of Health.

IU's M.D./Ph.D. program, in which students receive the both degrees in seven to eight years, has received a five-year, $1.25 million Medical Scientist Training Program award from the NIH, one of only 40 such grants to medical schools nationally.

The IU program is highly competitive, admitting just five recent under- graduates annually from more than 125 applications. Although many are from the Midwest, the program attracts applicants from across the country and from many of the nation's elite universities. The NIH funding will enable the program to expand its enrollment.

Ten graduate school programs participate in the program in addition to the School of Medicine, including the Weldon School of Biomedical Engineering at Purdue University.

The collaboration between the two universities was recognized by the NIH review panel as a compelling strength of the M.D./Ph.D program, one of the few in the nation to incorporate a strong engineering program in a significant way, said D. Wade Clapp, M.D., program director and Kipp Professor of Pediatrics and of microbiology and immunology at the IU School of Medicine. The program was also recognized for strengths in the IU School of Medicine clinical and graduate programs.

"Support from the NIH-sponsored Medical Scientist Training Program is recognition of the quality of our students, the program and the commitment made by IU and Purdue to meet the need for scientists who have received excellent training in both basic science and clinical research," said Dr. Clapp.

"We're delighted with the recognition from the NIH of the quality and potential of our joint program," said George Wodicka, Ph.D., head of Purdue's Weldon Sch
'/>"/>

Contact: Eric Schoch
eschoch@iupui.edu
317-274-7722
Indiana University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
2. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
3. $21.8 Million NIH Grant for Fragile X Research
4. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
5. Boston University School of Medicine researcher recipient of Memory Ride Grant
6. RAND researchers offer options to improve immigrant health care quality, access
7. Pennsylvania Department of Aging Receives Grant to Improve Alzheimers Support
8. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
9. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
10. Johns Hopkins receives $100 million grant to speed research from clinic to community
11. Major grant advances UWs clinical and translational research enterprise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ent Highlights Women,s Unmet Needs for HIV Prevent...n Family Planning Methods , , (Para tener a...stellano, vaya al sitio www.preventionnow.net .) ...nternational coalition of organizations that repre...United States is demanding increased access to the...
(Date:12/1/2008)...HONORED FOR CAREER OF SCIENTIFIC DISCOVERY IN MOLE...RNewswire/ -- The Radiologic Society of North Amer... its "Outstanding Researcher of The Year" Award, r...has made original significant contributions to the...h. Dr. Weissleder is Professor at Harvard Medical...
(Date:12/1/2008)... Zimmer Holdings, Inc.,(...ry A. McCaulley has joined the,Company as Preside...ility for,the Company,s activities in the reconst...g and Americas Sales. Mr. McCaulley will report t...ef Executive Officer. , "Jeff has a tremend...
(Date:12/1/2008)...PRNewswire/ -- One of America,s leading plastic,s...aking technique for inner,vaginal lip reduction k...ective. His study is published in the December 20... the official medical journal of the American Soci...er lip) reduction or labioplasty,is the most comm...
Breaking Medicine News(10 mins):Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 2Health News:Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom 3Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 2Health News:VisEn Co-Founder Named Radiologic Society's 'Outstanding Researcher of the Year' 3Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 2Health News:Zimmer Holdings Names Jeffery A. McCaulley President, Zimmer Reconstructive 3Health News:Plastic Surgery Journal Shows New Groundbreaking Genital Cosmetic Procedure for Women to be Successful 2
...ntries like Indonesia, the Unjted Nations health b...mised efforts would be made to ensure "fair and eq...s at affordable prices in the event of a pandemic....untries agreed to "timely sharing of viruses" with...
...oon on Monday at a meeting of the U.N. General Ass...S pandemic said he believes it is possible to hal...espite the increasing number of cases worldwide. ...wed pledges and set new targets to provide univers...
...entists has shown that a compound extracted from a...o reduce craving for marihuana, and block its effe...d based National Institute on Drug Abuse found tha...xtract, the rodents lose their hankering for a syn...
...ednesday the possibility that a resident of a prov...cted the lethal H5N1 strain of the bird flu virus,...k of bird flu has hit five provinces in Vietnam. A... lethal H5N1 strain after being hospitalized in se...
Other Medicine News:Health News:WHO Announces Deal on Sharing Bird Flu Virus 2Health News:U.N. Secretary-General Ban Renews Goal To Reverse Spread of HIV by 2015 2Health News:Compound Present in Plant may Help to Curb Craving for Cannabis 2
(Date:11/26/2008)...n., Nov. 26 Children wh...ignificantly increased risk of developing mental i...f a Mayo Clinic study published this month in Ped...demy of Pediatrics. , , The retrospective s...with strabismus (misaligned eyes) and compared the...
(Date:11/25/2008)... most respondents against expanding statin use bro...TLE FALLS, N.J., Nov. 25 JUPITER, ... the cardiovascular risk of healthy patients with ...se in older adults, according to a national poll d...ipants took part in the online poll conducted by m...
(Date:11/25/2008).... 25 CardioVascular,Bio...ounced today that it has,dosed the first patient ...I,clinical trial to treat patients with severe co... the treatment of CORonary heart Disease) trial wi...-controlled doses in approximately 120,patients w...
(Date:11/24/2008)...rms its innovation leadership and long-term commit...N.J., Nov. 24 Schering-P...clinical update on boceprevir, its lead investigat...y in Phase III development. The company believes ...s and best-in-class protease inhibitor for treatin...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 1UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 2UCSF faculty receive 2413 7M from CIRM for stem cell research 25576 3Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 1Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 2Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 3Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 25574 4VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 1VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 2VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 3VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 4VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 5VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 6VirtualHealth Technologies Inc Announces Its Associate Private Access Appoints Marc Kirshbaum as President 26 COO 25569 7New research on sexual function 25566 1New research on sexual function 25566 2
...ndicate early non-responders unlikely to subsequen...ts, and may benefit,from earlier change in treatme...07 /PRNewswire-FirstCall/,-- New data presented at...Research (ICOSR) suggest that antipsychotic drug,r...ght, and,challenge the current schizophrenia treat...
... Reduced By an Average of More Than Two Hours Per .../PRNewswire/ --,Adding the once daily, investigati...our(TM) Extended-Release Tablets to,Parkinson,s pa...cantly reduced ,off, time, allowing patients to co...of time. ,Off time,describes the return of Parkin...
Other Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Used for percutaneous placement of a pigtail catheter in the renal pelvis for nephrostomy drainage. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is
The BioPlex 2200 system is a fully automated bead-based multiplexing immunoassay platform that can deliver up to 2200 results per hour. The system will initially include a panel of assays targeting a
Medicine Products: